Advances in Drug Targeting Chemistry and Magnetic Fluid Dynamics for Enhanced Therapeutic Efficacy

Dear Colleagues,

The fields of drug targeting and nanomedicine have witnessed remarkable advancements over the past decade. The convergence of chemistry, materials science, and biomedical engineering has led to the development of sophisticated drug delivery systems capable of targeting specific cells, tissues, and organs. This targeted approach holds immense promise for increasing therapeutic efficacy while minimizing off-target side effects, thereby revolutionizing the treatment of a wide range of diseases, including cancer, neurodegenerative disorders, and infectious diseases.

A particularly promising area of research is the use of magnetic nanoparticles for drug delivery. Guided by external magnetic fields, these nanoparticles can be precisely steered to the desired site of action, offering an unprecedented level of control over drug distribution. This Special Issue will focus on the latest breakthroughs in the "drug targeting chemistry" that underpins these systems and the "magnetic fluid dynamics" that govern their transport and localization.

We believe that a Special Issue dedicated to this rapidly evolving and interdisciplinary field will be of great interest to your readership and will serve as a valuable resource for researchers and clinicians working at the forefront of nanomedicine and targeted therapeutics.

Dr. Abbas Sharifi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.